Skip to main content

Table 9 Reported adverse events

From: Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

Response Robenacoxib (s.c. + oral) Meloxicam s.c. + oral placebo P value (Fisher exact test)
Abdominal cavity hernia 0/101 (0%) 1/46 (2%) 0.31
Anorexia 1/101 (1%) 0/46 (0%) 1.0
Blood in faeces 1/101 (1%) 1/46 (2%) 1.0
Diarrhoea 7/101 (7%) 3/46 (7%) 1.0
Disorientation 1/101 (1%) 0/46 (0%) 1.0
Emesis 13/101 (13%) 5/46 (11%) 0.79
Eye redness 1/101 (1%) 0/46 (0%) 1.0
Loose stool 9/101 (9%) 4/46 (9%) 1.0
Muscle tremor 1/101 (1%) 0/46 (0%) 1.0
Pain not otherwise specified 0/101 (0%) 1/46 (2%) 0.31
Polydipsia 0/101 (0%) 1/46 (2%) 0.31
Prostration 1/101 (1%) 0/46 (0%) 1.0
Prolonged recovery 1/101 (1%) 0/46 (0%) 1.0
Sneezing 1/101 (1%) 0/46 (0%) 1.0
Spasm 0/101 (0%) 1/46 (2%) 0.31
Vocalisation 0/101 (0%) 1/46 (2%) 0.31
Uncoded sign 2/101 (2%) 1/46 (2%) 1.0
Any adverse event 30/101 (30%) 12/46 (26%) 0.70
  1. s.c.: subcutaneous.
  2. Data are number of cats with reported adverse event/total number of cats (%) in the whole study.